Skip to content

Clinical trials

Observational Hematologic Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Observational Country / region: Canada Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20141
20151
20182
20201
20212
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Enrolling by invitation2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adaptimmune2
Mount Sinai Hospital, Canada2
University of British Columbia2
Beckman Coulter, Inc.1
CRISPR Therapeutics AG1
Children's Oncology Group1
Kiadis Pharma1
Kite, A Gilead Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms11
Bronchiolitis Obliterans Syndrome2
Leukemia2
Neoplasm Metastasis2
Autoimmune Diseases1
Graft vs Host Disease1
Hemorrhage1
Leukemia, Myeloid, Acute1
Myelodysplastic Syndromes1
Neoplasms1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.